The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics". This cookie is set by GDPR Cookie Consent plugin. These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly. The company's devices are made in the United States. Today, Fisher Wallace Laboratories continues ground-breaking research at Harvard Medical School, Columbia Medical School, Massachusetts General Hospital, NYU Medical Center, University of Maryland, and the University of Medicine and Dentistry of New Jersey. military for use in treating three of the most common symptoms of Post Traumatic Stress Disorder (PTSD): depression, anxiety and insomnia.įounded by Charles Avery Fisher, the son of stereo pioneer Avery Fisher, Fisher Wallace Laboratories manufactures the Fisher Wallace Cranial Stimulator, a cranial electrotherapy stimulation (CES) device sanctioned by the FDA for the treatment of depression, anxiety and insomnia. Discounts are offered to members of the U.S. A prescription is required in the United States. The devise can be purchased through the Fisher Wallace website for $695 and can be used at home without medical supervision. Most recently, the device was used in a successful pilot program with 399 patients at Phoenix House, the nation's largest, non-profit drug and alcohol rehabilitation center. The Fisher Wallace Cranial Stimulator has been the subject of many peer-reviewed studies and pilot programs, all of which are documented on the company website. “This number shows the confidence leading doctors have in drug-free alternatives and suggests the beginning of a tipping point for our device.” “Knowing that two renowned psychiatrists have seen great results prescribing our Cranial Stimulator to more than 250 patients is an important milestone for Fisher Wallace,” said Chip Fisher, president of Fisher Wallace Laboratories. Also, patients who seek a drug-free alternative to treat insomnia have used the Cranial Stimulator to reduce or eliminate their dependence on prescription drugs.” San Martin said, “I have had great success using the device to treat severe, chronic insomnia in patients who are resistant to pharmacotherapy. Approximately 80 percent of my patients who have been diagnosed with generalized anxiety disorder, major depressive disorder, stress related disorders or insomnia have reported positive changes.”ĭr. Brown states, “I have seen very positive results, often within the first two weeks of using the device. San Martin, currently more than sixty doctors have prescribed the Cranial Stimulator to thousands of patients.ĭr. San Martin has prescribed it for the past three months. Brown has consistently prescribed the device for over a year and Dr. Andres San Martin is an assistant clinical professor of psychiatry, both at Columbia University. Richard Brown is an associate clinical professor of psychiatry and Dr. The handheld, FDA-sanctioned device generates micro-currents of electricity using patented radio frequencies that have been shown in several peer-reviewed studies to gently stimulate the brain's production of serotonin and dopamine (the neurochemicals required for psychological equilibrium and sound sleep).ĭr. Andres San Martin, have prescribed the Fisher Wallace Cranial Stimulator to more than 250 patients suffering from depression, anxiety and insomnia. 24 /PRNewswire/ - Fisher Wallace Laboratories today announced that two psychiatry professors at Columbia University, Dr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |